The overall objective of this program is to define the role of C reactive protein (CRP) in host defense mechanisms. It has been hypothesized, based largely on in vitro studies, that CRP functions during the early preimmune stages following inflammatory stimulus. A clear role for CRP during the course of inflammatory response in vivo has not been established. In the prior funding period the principal investigator has generated transgenic mice which express rabbit CRP with either a metallothionein (MTT) or PEPCK promoter which has made possible expression of CRP independent of inflammatory stimuli. These transgenic animals have been used in three mouse models of inflammation which include the systemic effects of LPS and PAF, a model of alveolar inflammation and a model of monoarticular arthritis. In all three systems CRP expressing transgenic mice have shown reproducible antiinflammatory effects. The present proposal is to extend the studies on the mechanisms of CRP as a participant in inflammation, The working hypotheses are that the effects of CRP are dependent on its ability to bind phosphocholine (PC), CRP can influence expression of cytokines and adhesion molecules, and antiinflammatory effects on antigen enduced arthritis are mediated by inhibition of T cell activation during the afferent arm of the immune process. These hypotheses will be tested by: 1) producing transgenic mice expressing a mutant CRP which has been designed to be incapable of PC binding; 2) measuring the effects of CRP on inflammatory cytokine gene expression in monocytes, splenocytes and neutrophils; and 3) manipulating the level of CRP before, during and after the initiation of the immune response in a model of arthritis to determine the effect of CRP on T cell activation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR040765-08
Application #
6055588
Study Section
Medical Biochemistry Study Section (MEDB)
Program Officer
Serrate-Sztein, Susana
Project Start
1991-08-01
Project End
2001-08-31
Budget Start
1999-09-01
Budget End
2001-08-31
Support Year
8
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Jiang, S; Xia, D; Samols, D (2006) Expression of rabbit C-reactive protein in transgenic mice inhibits development of antigen-induced arthritis. Scand J Rheumatol 35:351-5
Black, Steven; Agrawal, Alok; Samols, David (2003) The phosphocholine and the polycation-binding sites on rabbit C-reactive protein are structurally and functionally distinct. Mol Immunol 39:1045-54
Xia, D; Samols, D (1997) Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. Proc Natl Acad Sci U S A 94:2575-80
Zhang, D; Sun, M; Samols, D et al. (1996) STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J Biol Chem 271:9503-9
Zhang, D; Xia, D; Samols, D (1995) Generation of deletion mutants by partial digestion. Biotechniques 18:750-2
Lin, C S; Xia, D; Yun, J S et al. (1995) Expression of rabbit C-reactive protein in transgenic mice. Immunol Cell Biol 73:521-31
Renia, L; Rodrigues, M M; Nussenzweig, V (1994) Intrasplenic immunization with infected hepatocytes: a mouse model for studying protective immunity against malaria pre-erythrocytic stage. Immunology 82:164-8
Renia, L; Xia, D; Samols, D et al. (1993) Transgenic mice expressing C-reactive protein are susceptible to infection with Plasmodium yoelii sporozoites. Infect Immun 61:348-9